Yokohama City University - Tsurumi Campus

Doctor of Philosophy in Structural Biology and Supramolecular Medicine

Advanced doctoral research co-supervised with RIKEN scientists, utilizing 950 MHz NMR and cryo-electron microscopy to resolve atomic structures of membrane receptors and oncogenic protein complexes.

Type

Degree Program

Deadline

December 15, 2026 (April 2027 Intake) / June 15, 2027 (October Intake)

Funding

MEXT Monbukagakusho University Recommendation Scholarship (¥145,000/month stipend plus full tuition waiver) and YCU Doctoral Research Fellowships

Master of Science in Medical Life Science and Computational Drug Discovery

English-taught postgraduate program integrating structural biology, molecular dynamics simulations, AI-driven ligand screening, and peptide chemical synthesis.

Type

Degree Program

Deadline

January 10, 2027

Funding

YCU International Student Tuition Exemption (50% to 100% tuition waiver) and JASSO Honors Scholarships

YCU-RIKEN Joint Structural Biology Research Fellowship

Competitive visiting fellowship supporting graduate researchers conducting synchrotron beamline experiments and high-throughput fragment screening at the RIKEN-YCU alliance facilities in Tsurumi.

Type

Fellowship

Deadline

March 31, 2027

Funding

Monthly research stipend of ¥180,000 plus dedicated access to cryo-EM instruments and laboratory consumable budget

Graduate Certificate in Cryo-Electron Microscopy and Biomolecular Modeling

Specialized technical certificate providing hands-on training in single-particle cryo-EM sample vitrification, high-resolution image processing (RELION/CryoSPARC), and atomic model refinement.

Type

Degree Program

Deadline

April 15, 2027

Funding

Tuition reduction grants for doctoral candidates enrolled in affiliated Japanese medical universities

YCU Global Medical Innovator Scholarship

Endowed scholarship for exceptional international postgraduate scholars pursuing cancer immunotherapy and neurodegenerative biomarker discovery at the Tsurumi Campus.

Type

Scholarship

Deadline

February 28, 2027

Funding

¥100,000 monthly living stipend and 100% admission fee waiver

Master of Science in Clinical Proteomics and Metabolomics

Advanced program focused on tandem mass spectrometry, clinical lipidomics, single-cell protein profiling, and disease biomarker validation in human patient cohorts.

Type

Degree Program

Deadline

January 10, 2027

Funding

Japan Student Services Organization (JASSO) grants and Kanagawa Prefecture healthcare research stipends

YCU Tsurumi Postdoctoral Fellowship in Chemical Epigenetics

Two-year postdoctoral fellowship investigating histone methyltransferase inhibitors, chromatin remodeling kinetics, and epigenetic drug design targeting leukemia.

Type

Fellowship

Deadline

March 15, 2027

Funding

¥4,800,000 annual research salary plus full institutional lab access and international symposium funding

Prof. Dr. Yoshifumi Nishimura

Specially Appointed Professor of Structural Biology and Former Dean · Graduate School of Medical Life Science

Prof. Dr. Yoshifumi Nishimura is a world-renowned pioneer in biomolecular NMR, elucidating the three-dimensional structures of human transcription factors, DNA-binding homeodomains, and epigenetic histone modifications.

Prof. Dr. Jeremy R. H. Tame

Professor of Protein Engineering and Structural Biophysics · Graduate School of Medical Life Science

Prof. Dr. Jeremy R. H. Tame investigates macromolecular allostery and symmetrical protein architectures, designing synthetic repeat proteins and catalytic enzymes for bio-industrial applications.

Prof. Dr. Tatsuya Niimi

Professor of Supramolecular Biochemistry and RNA Therapeutics · Laboratory of Structural Biology

Prof. Dr. Tatsuya Niimi leads structural studies into eukaryotic spliceosomes and non-coding RNA complexes, utilizing high-resolution cryo-EM to unravel molecular targets for genetic disorders.

Prof. Dr. Masahiko Sato

Professor of Molecular Pharmacology and Drug Discovery · Department of Pharmaceutical Chemistry

Prof. Dr. Masahiko Sato designs novel bifunctional degraders and kinase inhibitors, integrating structural biophysics with medicinal chemistry to overcome multidrug-resistant malignancies.